Today: 19 May 2026
Tesco share price slips as grocery inflation cools — 3 dates investors are watching
3 February 2026
1 min read

Tesco share price slips as grocery inflation cools — 3 dates investors are watching

London, Feb 3, 2026, 08:36 GMT — Regular session

  • Tesco shares slipped in early trading, reversing some of Monday’s gains.
  • UK grocery inflation slowed to 4.0%, with Tesco expanding its market share, according to industry data.
  • Attention shifts to the Bank of England on Feb. 5, with UK CPI data due Feb. 18 and Tesco’s earnings set for April 16.

Tesco shares edged down 0.1% to 430.9 pence shortly after the open, starting at 430.4 pence and dipping as low as 426.1 pence for a moment.

The stock is reacting to new data on UK grocery price growth — a shift that can swiftly change shopper habits and how aggressively supermarkets roll out promotions.

Food inflation matters now since it takes up a large chunk of household budgets and influences the broader inflation picture policymakers consider when adjusting interest rates.

UK grocery inflation dropped to 4.0% in the four weeks ending Jan. 25, hitting its lowest level since April, down from 4.3% in the prior period, according to Worldpanel by Numerator. Fraser McKevitt noted shoppers were still focused on value, with own-label products accounting for 52.2% of spending. Over the 12 weeks to Jan. 25, Tesco’s sales climbed 4.4%, lifting its market share by 20 basis points to 28.7%. J Sainsbury, Lidl, and Ocado saw faster growth, while Asda fell behind.

The early drop comes after a solid day for Tesco. On Monday, shares climbed 1.46% to 4.31 pounds, while the FTSE 100 notched a 1.15% gain, closing at a record high, according to MarketWatch data.

Company news was sparse. On Monday, Tesco released a regulatory update confirming it had 6,385,182,796 ordinary shares outstanding as of Jan. 31, with no shares held in treasury. This routine disclosure supports UK transparency requirements.

Rates take center stage this week as the Bank of England prepares to release its February policy decision and meeting minutes on Thursday.

Investors are eyeing a key date: the UK’s consumer price inflation figures for January drop on Feb. 18 at 0700 GMT, per the Office for National Statistics.

Tesco’s next major company update won’t come until April 16, when it releases preliminary results for the 2025/26 fiscal year.

But lower grocery inflation isn’t all good news. If prices drop faster than costs do, retailers may have to offer bigger discounts to keep sales up, squeezing margins even as customers get some break at the checkout.

Next up: the Feb. 5 rate decision and the Feb. 18 CPI data. After that, all eyes shift to Tesco’s April 16 earnings, where investors will see if market share gains are translating into profits and cash flow.

Stock Market Today

  • Deutsche Bank Sees No Immediate Threat to Risk Assets Amid Energy Concerns
    May 19, 2026, 10:05 AM EDT. Deutsche Bank analysts stated that the current environment lacks the conditions that triggered aggressive selloffs in riskier assets during past energy shocks. They suggest investors need not worry about immediate pressure on risk assets, which include stocks and high-yield bonds, despite recent market volatility linked to energy sector developments.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Vertiv shares slide ahead of AI data center update

Vertiv shares slide ahead of AI data center update

18 May 2026
Vertiv Holdings shares dropped 8.5% to $339.41 on Monday, erasing over $12 billion in market value ahead of a key investor conference. Trading volume reached about 7 million shares. The decline outpaced peers as U.S. tech stocks fell broadly. Vertiv urged shareholders to reject a mini-tender offer from Tutanota LLC for up to 500,000 shares.
Northern Star share price rebounds after gold shock; NST’s Feb. 12 results loom
Previous Story

Northern Star share price rebounds after gold shock; NST’s Feb. 12 results loom

Venezuela oil exports jump, but Exxon Mobil and Chevron still won’t bet big
Next Story

Venezuela oil exports jump, but Exxon Mobil and Chevron still won’t bet big

Go toTop